Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Il Dong Pharmaceutical Co., Ltd. (249420:KRX), powered by AI.
Il Dong Pharmaceutical Co., Ltd. is currently trading at ₩26,500. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Il Dong Pharmaceutical Co., Ltd. on Alpha Lenz.
Il Dong Pharmaceutical Co., Ltd.'s P/E ratio is -161.8.
“Il Dong Pharmaceutical Co., Ltd. trades at a P/E of -161.8 (undervalued) with modest ROE of -2.8%.”
Ask for details →Il Dong Pharmaceutical Co., Ltd. is a leading company in the pharmaceutical industry, dedicated to developing, manufacturing, and distributing a diverse range of healthcare products. Primarily engaged in the production of pharmaceutical drugs, Il Dong focuses on the R&D of innovative treatments that address a broad spectrum of health conditions. The company's product portfolio includes prescription medications, over-the-counter drugs, and health supplements, catering to various medical fields such as cardiology, neurology, and gastroenterology. Il Dong Pharmaceutical plays a significant role in the healthcare sector by providing high-quality medicines and collaborating with healthcare professionals to enhance patient care. With a robust distribution network, the company ensures that its products are accessible to hospitals, clinics, and pharmacies, both domestically and internationally, thereby contributing substantially to the global pharmaceutical market.
“Il Dong Pharmaceutical Co., Ltd. trades at a P/E of -161.8 (undervalued) with modest ROE of -2.8%.”
Ask for details →Il Dong Pharmaceutical Co., Ltd. (ticker: 249420) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 1,067 employees. Market cap is $838.4B.
The current price is ₩26,500 with a P/E ratio of -161.75x and P/B of 4.6x.
ROE is -2.77% and operating margin is 2.14%. Annual revenue is $614.9B.